FDA Awarded a National Priority Voucher to Teclistamab with Daratumumab for R/R Multiple Myeloma

Teclistamab

Tom Powles: Another Step Towards Curing Bladder Cancer

Thomas Powles tom powles

David Steensma: Ajax Therapeutics Receives Orphan Drug Designation by FDA for AJ1-11095 for the Treatment of Myelofibrosis

David Steensma

ASCO Joins One Voice Against Cancer’s Day of Action Urging Congress to Pass a Final Labor-HHS Funding Bill

ASCO

Maryam Lustberg: From Phase 2 Promise to Phase 3 Proof in Neuropathy Prevention

Maryam Lustberg

Oncology News, Insights, Stories by OncoDaily

Childhood Cancer Advocacy
Voices

Major Win for Childhood Cancer Advocacy: UN Adopts GICC Target

Marty Makary
Voices

Marty Makary: FDA Rejection Letters are Now Public

FDA Approves RYBREVANT FASPRO as the First Subcutaneous Amivantamab Option for EGFR-Mutated NSCLC
FDA Approvals

FDA Approves RYBREVANT FASPRO as the First Subcutaneous Amivantamab Option for EGFR-Mutated NSCLC

Perioperative PADCEV Plus Pembrolizumab Significantly Improves Survival in Cisplatin-Eligible Muscle-Invasive Bladder Cancer

IASLC Language Guide for Oncologists: What to Say and What Not to

What Did We Learn from the World Cancer Leaders Summit Report?

Pfizer, Astellas and Merck Against Bladder Cancer

Alicia Zhou: Building the Data-First Future of Immunotherapy

IASLC Announces the Co-Chairs for the 2027 World Conference on Lung Cancer

Georgios Giamas: Honored to Serve as Editor-in-Chief of Oncogene from 2026

OncoThon 2026
OncoDaily 100
Act 4 Children
Grand Rounds GI
OncoDaily Party: Berlin 2025
awards
awards
awards
awards
awards
awards

Voices
Birgitta Ohlsson Klamberg: US Cancer Research Cuts Force Push Researchers into Clinical Practice

Birgitta Ohlsson Klamberg: US Cancer Research Cuts Force Push Researchers into Clinical Practice

Christian Hyde: Proton Therapy Improves Survival and Quality of Life for Oropharyngeal Cancer Patients

Nirmala Bhoo Pathy: Year-End Reflections on Advancing Health Systems in LMICs

Eva Schumacher-Wulf Shares Highlights from SABCS 2025 and Key Breast Cancer Updates

CCI Europe Calls on EU Member States to Safeguard Funding for Health and Civil Society

Sahar Mansour: Excited to Discuss AI Practice for Breast Cancer Screening at GUC Winter School

Abdu Adem Yesufe: Advanced HER2+ Breast Cancer Treatments Remain Out of Reach for LMICs

Celebrities and Cancer

OncoCalendar

Best of SABCS – West

Association of Northern California Oncologists

14 Feb
SABCS

ANCO's Hematologic Malignancies Update 2026

Association of Northern California Oncologists

02 May
ANCO

26th Multidisciplinary Management of Cancers: A Case-Based Approach

Association of Northern California Oncologists

06 Mar
cancers

ANCO's Clinical Cancer Update 2026

Association of Northern California Oncologists

23 Jan
anco

ANCO’s Medicare Regulations Update 2026

Association of Northern California Oncologists

14 Jan
ANCO

Immune-oncology
10 Must-Read Posts in Immuno-Oncology This Week

10 Must-Read Posts in Immuno-Oncology This Week

Positive Topline Results from Phase 3 RINGSIDE Trial: Varegacestat Significantly Improves Outcomes in Desmoid Tumors

How Do Pharmacists Protect the Safety and Effectiveness of Immunotherapy?

10 Must-Read Posts in Immuno-Oncology This Week

10 Must-Read Posts in Immuno-Oncology This Week

The "Off-the-Shelf" Revolution: How iNKT Cell Therapy agenT-797 is Reprogramming the Fight Against Solid Tumors

10 Posts Not to Miss from ESMO

OncoGrants
Cancer Research Internship Summer Program (CRISP) – IU Simon Comprehensive Cancer Center

Cancer Research Internship Summer Program (CRISP) – IU Simon Comprehensive Cancer Center

Summer Imaging Research Program - MD Anderson Cancer Center

Summer Imaging Research Program - MD Anderson Cancer Center

Breakthrough Cancer Research Education and Travel Award

Breakthrough Cancer Research Education and Travel Award

Breakthrough Cancer Research Summer Student Scholarship

Breakthrough Cancer Research Summer Student Scholarship

Breakthrough Cancer Research Cancer Research PhD Scholarships

Breakthrough Cancer Research Cancer Research PhD Scholarships

Shade Grant Initiative (Cancer Council SA / Preventive Health SA)

Shade Grant Initiative (Cancer Council SA / Preventive Health SA)

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Colorectal Cancer

Colorectal Cancer: Epidemiology, Pathogenesis, Diagnosis, and Therapeutic Advances

Cholangiocarcinoma: Latest Risk Factors, Symptoms, Diagnosis, and 2025 Advanced Treatment Options for Bile Duct Cancer

Pheochromocytoma: Causes, Diagnosis, Treatment, and Breakthrough 2025 Advances in Management

Cervical Cancer: Symptoms, Causes, Stages, Diagnosis and Treatment

Craniopharyngioma: Symptoms, Diagnosis, Treatment, and 2025 Breakthroughs in Targeted Therapy and Precision Care

Malignant Schwannoma: Comprehensive Guide to Causes, Symptoms, Diagnosis, Treatment, Prognosis, and 2025 Advances in Schwannoma Care

Meningioma: Types, Symptoms, Diagnosis, Treatment, Malignancy Risk, and 2025 Breakthroughs

CancerWorld
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards

Oncologists
Layth Mula-Hussain

Layth Mula-Hussain

Prince George, Canada
Eric Van Cutsem

Eric Van Cutsem

Leuven, Belgium
Leandro Jonata de Carvalho Oliveira

Leandro Jonata de Carvalho Oliveira

São Paulo, Brazil
Justin Nathaniel Baker

Justin Nathaniel Baker

Stanford, USA
Gregory Kalemkerian

Gregory Kalemkerian

Ann Arbor, USA
Mohamed Emam Sobeih

Mohamed Emam Sobeih

Giza, Egypt
Jasmine Kamboj

Jasmine Kamboj

Red Wing, USA
Alexandra Müller

Alexandra Müller

Freiburg, Germany

Oncology Drugs
Tremelimumab (Imjudo)

Tremelimumab (Imjudo) Updates 2025: Uses in Cancer, Dosage, Side Effects, Expectations, and More

Darovasertib for Uveal Melanoma: What Patients Need to Know

Darovasertib: A Deep Dive Into a First-in-Class PKC Inhibitor Reshaping the Treatment Landscape of Metastatic Uveal Melanoma

Amivantamab for Lung Cancer: What Patients Need to Know

Amivantamab: A Deep Dive Into Its Mechanism, Clinical Data, and Expanding Role in EGFR-Driven Non–Small Cell Lung Cancer

Relacorilant: A New Treatment Approach for Women With Platinum-Resistant Ovarian Cancer

Relacorilant: A Selective Glucocorticoid Receptor Modulator Reshaping Treatment in Platinum-Resistant Ovarian Cancer

OncoDaily Magazine
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards

New Paper Alert
New GI Paper Alert for colorectal cancer

New GI Paper Alert: Survival outcomes of ERBB2-amplified metastatic colorectal cancer treated with first-line chemotherapy

CHRYSALIS-2 Trial

Treatment Outcomes With Amivantamab–Lazertinib in EGFR Mutant NSCLC: CHRYSALIS-2 Trial

GCD vx GCS

New GI Paper Alert: Durvalumab plus gemcitabine-cisplatin versus S-1 plus gemcitabine-cisplatin in advanced biliary tract cancer.

INTERACT-ION Trial

INTERACT-ION Trial: Ezabenlimab Plus mDCF Induction Improves Complete Response Rates in Anal Cancer

CCL7 Macrophages

CCL7-Positive Tumor-Associated Macrophages Drive Immune Checkpoint Resistance in Colorectal Cancer

TRYBECA-1 Trial

TRYBECA-1 Trial: Eryaspase Added to Second-Line Chemotherapy in Advanced PDAC

OncoDaily Medical Journal

Precision Oncology

10.69690/ODMJ-019-0829-4588

Harnessing Real-World Evidence to Support Precision Oncology
Opinion

Pediatric Oncology

10.69690/ODMJ-001-0829-4568

Identifying the Factors Contributing to Treatment Abandonment in Childhood Cancers at a Tertiary Care Hospital in Pakistan
Original Research

Global Oncology

10.69690/ODMJ-001-0811-4701

The Role of National and Regional Cancer Registries in Shaping Cancer Care Policies
Original Research

Pediatric Oncology

10.69690/ODMJ-001-0809-4599

Survival Outcomes of Wilms' Tumor in Pediatric Patients Treated at KFMC: A Retrospective Study of 15 years from 2007-2022
Original Research

GI Oncology

10.69690/ODMJ-018-0425-4320

Colorectal Cancer in Latin America: Quick Comment
Commentaries

GI Oncology

10.69690/ODMJ-002-0701-4309

Current Perspective of Gastro-intestinal Cancer in Guatemala
Review/Meta-Analysis

Pediatric Oncology

10.69690/ODMJ-003-0520-4233

In the Crossfire: A Call for Peace from the Frontlines of Pediatric Oncology by the POEM Group
Editorial

Pediatric Oncology

10.69690/ODMJ-018-0425-4062

CD19+ CAR-T Therapy for Relapsed or Refractory B-ALL and Burkitt Lymphoma in Children and Young Adults in the Republic of Belarus
Abstracts